The pathogenesis of MM is closely linked to proteostasis imbalance caused by genetic events and alterations in the BM microenvironment, involving oncogene overexpression (e.g., MYC, MAF) and mutations (e.g., KRAS, NRAS, p53) (Malard et al., 2024). The gene discussed is MAF; the disease is Miyoshi myopathy.